IL-20 antagonist suppresses PD-L1 expression and prolongs survival in pancreatic cancer models
The pro-inflammatory cytokine IL-20 promotes tumor growth in several cancer types. Here, the authors show that high levels of IL-20 are associated with poor survival in patients with pancreatic ductal adenocarcinoma (PDAC) and that IL-20 blockade reduces tumor growth and alleviates cachexia symptoms...
Saved in:
Main Authors: | Shao-Wei Lu, Hong-Chin Pan, Yu-Hsiang Hsu, Kung-Chao Chang, Li-Wha Wu, Wei-Yu Chen, Ming-Shi Chang |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/daecbc35c3a24e828aa4c37a7583f7d1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tenofovir Hampers the Efficacy of Sorafenib in Prolonging Overall Survival in Hepatocellular Carcinoma
by: Kung-Hao Liang, et al.
Published: (2021) -
Noise suppression in PD signal based on Prony time series energy spectrum
by: Chang Wang, et al.
Published: (2022) -
Improved resection and prolonged overall survival with PD-1-IRDye800CW fluorescence probe-guided surgery and PD-1 adjuvant immunotherapy in 4T1 mouse model
by: Du Y, et al.
Published: (2017) -
IL-10 suppression of NK/DC crosstalk leads to poor priming of MCMV-specific CD4 T cells and prolonged MCMV persistence.
by: Sanja Mandaric, et al.
Published: (2012) -
The Potential Advantage of Targeting Both PD-L1/PD-L2/PD-1 and IL-10–IL-10R Pathways in Acute Myeloid Leukemia
by: Laura Jimbu, et al.
Published: (2021)